Government maintains access to fast acting insulin

17 March 2023 - The Albanese Government has secured access to Fiasp and Fiasp FlexTouch on the PBS for Australians ...

Read more →

CEO’s appointment to HTA Review Reference Committee

15 March 2023 - CEO of Medicines Australia, Elizabeth de Somer, has been appointed as the medicines industry representative on ...

Read more →

AMA urges immediate action to save patients on PBS medicines

9 March 2023 - The AMA has urged all members of the Federal Parliament to support the AMA’s campaign to bring ...

Read more →

Updates from the Health Technology Assessment Policy and Methods Review Reference Committee (March 2023)

9 March 2023 - The Health Technology Assessment Policy and Methods Review Reference Committee met on 13 February 2023.  ...

Read more →

DoH makes further tweaks to the agenda for this week's PBAC meeting

7 March 2023 - We are now at version 4 with four revisions. ...

Read more →

Catherine has stage four breast cancer, but she can't access a new treatment in Australia

3 March 2023 - In 2015, twelve weeks after the birth of her second daughter, Catherine King was diagnosed with late-stage ...

Read more →

3.2 million cheaper medicine in 2023

5 March 2023 - Australians are being encouraged to fill their prescriptions for medicines, especially as the maximum out of pocket ...

Read more →

Public Summary Documents – November 2022 PBAC meeting (round 1)

3 March 2023 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the November 2022 PBAC ...

Read more →

DoH tweaks the agenda for next week's PBAC meeting (2023/1)

3 March 2023 - We are now up to version 3; six revisions including two withdrawn submissions. ...

Read more →

Ultra-fast insulin drug Fiasp to be removed from PBS making it unaffordable for many diabetes sufferers

2 March 2023 - For the past six months, 14-year-old Freya Goldston has attended more school, swimming training and increased her ...

Read more →

Affordable treatment for recurrent melanoma

2 March 2023 - From 1 March 2023, Australians with recurrent melanoma will have a new treatment option subsidised by the ...

Read more →

Schedule of Pharmaceutical Benefits - 1 March 2023

1 March 2023 - The March 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Recommendations made out of session by the PBAC November 2022 and March 2023 meetings

24 February 2023 - Recommendations made out of session by the PBAC between its November 2022 and March 2023 meetings are ...

Read more →

Improve ventilation and make antiviral drug widely available, long COVID inquiry hears

20 February 2023 - GPs say they are unable to properly care for the hundreds of thousands of Australians with ...

Read more →

1.6 million cheaper medicines in January

19 February 2023 - New analysis by the Department of Health and Aged Care shows that more than 1.6 million prescriptions ...

Read more →